Skip to main content
AMRX logo

AMRX · Amneal Pharmaceuticals, Inc.

$17.92 -0.05 (-0.28%) At close · Jul 24
Market Cap
$5.72B
Shares
319.02M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Chintu Patel $8,730,545
Chirag Patel $8,691,745
Anastasios Konidaris $3,293,494
Andrew Boyer $3,017,163
Jason Daly $2,860,442
Nikita Shah $2,730,582
Fiscal 2024
Executive Total
Chintu Patel $7,191,109
Chirag Patel $7,187,970
Anastasios Konidaris $2,852,333
Andrew Boyer $2,794,302
Jason Daly $2,383,794
Nikita Shah $2,373,664
Fiscal 2023
Executive Total
Chirag Patel $2,370,386
Chintu Patel $2,367,553
Andrew Boyer $1,942,689
Anastasios Konidaris $1,891,266
Nikita Shah $1,533,232
Jason Daly $1,349,396
Fiscal 2022
Executive Total
Chintu Patel $5,062,732
Chirag Patel $5,048,110
Anastasios Konidaris $2,733,186
Andrew Boyer $2,681,937
Nikita Shah $2,258,859
Jason Daly $1,720,937
Fiscal 2021
Executive Total
Chintu Patel $4,798,825
Chirag Patel $4,785,116
Anastasios Konidaris $2,663,996
Andrew Boyer $2,635,863
Nikita Shah $2,223,694
Joseph Todisco $2,156,610
Fiscal 2020
Executive Total
Anastasios Konidaris $2,508,499
Andrew Boyer $2,386,531
Chintu Patel $2,328,528
Chirag Patel $2,320,716
Nikita Shah $1,777,720
Joseph Todisco $1,671,129
Todd P. Branning $1,270,412
Fiscal 2019
Executive Total
Robert A. Stewart $9,525,800
Paul Bisaro $4,119,314
David A. Buchen $3,651,747
Pradeep Bhadauria $3,356,829
Andrew Boyer $3,113,079
Todd P. Branning $2,655,963
Nikita Shah $2,541,929
Bryan Reasons $1,851,479
Chintu Patel $339,600
Chirag Patel $337,967
Fiscal 2018
Executive Total
Robert A. Stewart $11,683,805
Paul Bisaro $6,066,025
Andrew Boyer $3,861,506
Bryan Reasons $2,364,271
Nikita Shah $1,285,349
Fiscal 2017
Executive Total
Paul Bisaro $6,532,512
Bryan Reasons $1,314,034
Key facts CIK 1723128 CUSIP 03168L105 13F (30d) 53 filings 53 filers Visit website Investor relations